(Q41623144)

5 October 2017

1 reference

title

The use of lidocaine as a test of liver function in liver transplantation (English)

1 reference

5 October 2017

0 references

J M Potter

1

1 reference

5 October 2017

M Oellerich

series ordinal

2

1 reference

5 October 2017

publication date

1 May 1996

1 reference

5 October 2017

published in

Liver Transplantation

1 reference

5 October 2017

volume

2

1 reference

5 October 2017

issue

3

1 reference

5 October 2017

page(s)

211-224

1 reference

Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Assessment of the (14C) aminopyrine breath test in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Clinical Pharmacokinetics of Lignocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Evidence for pre-hepatic metabolism of oral cyclosporine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Extrahepatic production of the lignocaine metabolite monoethylglycinexylidide (MEGX)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Assessment of lidocaine metabolite formation as a quantitative liver function test in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Lignocaine metabolite formation as a measure of pre-transplant liver function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Selection criteria for liver transplant donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Effect of hypoxia on the hepatic metabolism of lidocaine in the isolated perfused pig liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

Quantitative Assessment of Deranged Hepatic Function: A Missed Opportunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020307

21 January 2018

Identifiers

DOI

10.1002/LT.500020307

1 reference

5 October 2017

1 reference